Improving Access to Healthcare in Low- and Middle-Income Countries (LMICs)
Swiss TPH Symposium in collaboration with Healthcare Dialogues
8 February 2024
Kreuzstrasse 2, 4123 Allschwil, Switzerland
Improving access to healthcare in low- and middle-income countries (LMICs) is a global issue. On 8 February 2024, Swiss TPH will bring together experts and key players from the pharmaceutical industry, academia and product development partnerships to assess current strategies and progress and to foster synergies between partners for more effective product development, licensing and implementation. Join us for this multidisciplinary networking event organised in collaboration with Healthcare Dialogues.
Sessions will include:
- The Potential of Local Cooperation on a Global Scale
- Access to Drugs, Diagnostics and Vaccines
- Promoting and Improving Availability
- Working Together to Improve Access
Information
Eva Herzog
President of the Swiss Council of States
Jürg Utzinger
Director, Swiss TPH
Pierre Morgon
CEO and Founder, MRGN Advisors
Jan Van Acker
Strategic Healthcare and Biopharma Advisor, former President of Emerging Markets MSD
Sandy Johnston
Virtual Doctors
Teresa Graham
CEO Pharmaceuticals, F. Hoffmann-La Roche
Daniel Paris
Head of Medicine, Swiss TPH
Sabine Specht
Head of Filarial Clinical Trial Program, Drugs for Neglected Diseases initiative
Honorati Masanja
Chief Executive Director, Ifakara Health Institute
Lutz Hegemann
President of Global Health and Sustainability, Novartis
Stefan Seliger
Head of Global Access and Policy, Diagnostics, F. Hoffmann-La Roche
Elisabeth Reus
Unit Head, Clinical Operations, Swiss TPH
Jutta Reinhard-Rupp
Head of Global Health Institute, Merck
Thursday, 8 February 2024
12:15 Light Lunch and Registration
The Potential of Local Cooperation on a Global Scale
| 13:00 | Welcome and Introduction, Daniel Paris, Head of Medicine, Swiss TPH | |
| 13:15 | The Role of Switzerland in Promoting Global Health, Eva Herzog, President of the Swiss Council of States | |
| 13:30 | Improving Access to Medicines - The Roche Approach, Teresa Graham, CEO Pharmaceuticals, F. Hoffmann-La Roche | |
| 13:50 | The Role of the Private Sector in Expanding Access to Healthcare in LMICs, Lutz Hegemann, President of Global Health and Sustainability, Novartis |
Access to Drugs, Diagnostics and Vaccines
| 14:10 | Health Equity and Access to Diagnostics in LMICs, Stefan Seliger, Head of Global Access and Policy, Diagnostics, F. Hoffmann-La Roche | |
| 14:30 | Manufacturing and Supply of Vaccines in LMICs, Pierre Morgon, CEO & Founder, MRGN Advisors | |
| 14:50 | Improving Access for NTDs Drugs in LMICs, Sabine Specht, Head of Filarial Clinical Trial Program, Drugs for Neglected Diseases initiative | |
| 15:10 | Coffee Break (30 minutes) |
Promoting and Improving Availability
| 15:40 | How Can Multinational Corporations Contribute to Improving Access to Medicines in LMICs? Jan Van Acker, Strategic Healthcare and Biopharma Advisor, former President of Emerging Markets, Merck Sharp Dohme Pharma | |
| 16:00 | LMIC Partnerships to Improve Access, Honorati Masanja, Ifakara Health Institute | |
| 16:20 | Access to Medicines and Health Products – the Case of Arpraziquantel, Jutta Reinhard-Rupp, Head of Global Health Institute, Merck | |
| 16:40 | Translational Research, PDPs and Partnerships in LMICs, Daniel Paris, Head of Medicine, Swiss TPH |
How Can We Work Together Better to Improve Access?
| 17:00 | Panel Discussion with Q&A, T. Graham, L. Hegemann, S. Seliger, P. Morgon, S. Specht, J. van Acker, H. Masanja, J. Reinhard-Rupp, D. Paris | |
| 17:30 | Closing Words, Jürg Utzinger, Director, Swiss TPH | |
| 17:40 | Networking Apéro | |
| 19:00 | End of Event |